Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma

被引：1
|
作者：
Long, Georgina, V [1 ]
Luke, Jason J. [2 ]
Fukunaga-Kalabis, Mizuho [3 ]
Asierto, Paolo A. [4 ]
机构：
[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2060, Australia
[2] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] Ist NazionaleTumori IRCCS Fdn Pascale, Naples, Italy
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 01期
关键词：
D O I：
10.1016/S1470-2045(22)00753-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E8 / E8
页数：1
相关论文
共 50 条
  • [31] Re: Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival
    Taguchi, Satoru
    Fukuhara, Hiroshi
    Homma, Yukio
    [J]. JOURNAL OF UROLOGY, 2017, 198 (01): : 212 - 213
  • [32] Predicted vs Observed Metastasis-Free Survival in Individuals With Uveal Melanoma
    Singh, Arun D.
    Binkley, Elaine M.
    Wrenn, Jacquelyn M.
    Bena, James F.
    Hinz, Connie
    Boldt, H. Culver
    [J]. JAMA OPHTHALMOLOGY, 2022, 140 (09) : 847 - 854
  • [33] Choroidal melanoma: Predicted metastasis-free Survival worse than observed
    Bitzer, Michaela
    [J]. AUGENHEILKUNDE UP2DATE, 2023, 13 (02) : 95 - 95
  • [34] Safety of pembrolizumab for resected stage III melanoma
    Pham, F.
    Dalle, S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (10) : 1221 - 1227
  • [35] Pembrolizumab increases survival in resected advanced melanoma
    不详
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (08) : 1676 - 1676
  • [36] Re: Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival Reply
    不详
    [J]. JOURNAL OF UROLOGY, 2017, 198 (01): : 213 - 214
  • [37] Disease-free survival (DFS) and distant metastasis-free survival (DMFS) as surrogates for overall survival (OS) in adjuvant treatment of muscle-invasive bladder cancer (MIBC)
    Sternberg, C.
    Squifflet, P.
    Burdett, S.
    Fisher, D.
    Saad, E. D.
    Kurt, M.
    Teitsson, S.
    May, J. R.
    Stoeckle, M.
    Torti, F.
    Cote, R.
    Groshen, S.
    Ruggeri, E.
    Zhegalik, A.
    Tierney, J.
    Collette, L.
    Burzykowski, T.
    Buyse, M. E.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1335 - S1336
  • [38] COLUMBUS-AD: phase III study of adjuvant encorafenib plus binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma
    van Akkooi, Alexander C. J.
    Hauschild, Axel
    Long, Georgina, V
    Mandala, Mario
    Kicinski, Michal
    Govaerts, Anne-Sophie
    Klauck, Isabelle
    Ouali, Monia
    Lorigan, Paul C.
    Eggermont, Alexander M. M.
    [J]. FUTURE ONCOLOGY, 2023, 19 (30) : 2017 - 2027
  • [39] Preoperative Pectoralis Muscle Index Predicts Distant Metastasis-Free Survival in Breast Cancer Patients
    Huang, Wen-juan
    Zhang, Meng-lin
    Wang, Wen
    Jia, Qing-chun
    Yuan, Jia-rui
    Zhang, Xin
    Fu, Shuang
    Liu, Yu-xi
    Miao, Shi-di
    Wang, Rui-tao
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] A Real World Study on Adjuvant Nivolumab: Recurrence Free Survival and Toxicity in Resected Stage III and IV Melanoma
    Huang, Wendy E.
    Archer, Christine
    Yip, Desmond
    Kanjanapan, Yada
    Peters, Geoffrey
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 173 - 174
12345